These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Reactivity of the cardiovascular system in rats]. Jacquey AM, Wepierre J. C R Seances Soc Biol Fil; 1971; 165(4):812-9. PubMed ID: 4401395 [No Abstract] [Full Text] [Related]
24. [Effect of peripheral serotonin antagonists and monoamine oxidase inhibitors on some central effects of indolalkylamines]. Gilev AP, Tetenchuk EV. Farmakol Toksikol; 1968; 31(2):159-63. PubMed ID: 5674667 [No Abstract] [Full Text] [Related]
25. [Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats]. Vysotskaia NB, Kaverina NV, Mirzoian RS, Rozonov IuB. Farmakol Toksikol; 1967; 30(3):289-92. PubMed ID: 5597732 [No Abstract] [Full Text] [Related]
26. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)]. Dénes B, Greeff K, Tawfik H. Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481 [Abstract] [Full Text] [Related]
27. Interactions of ketamine with vasoactive amines at normothermia and hypothermia in the isolated rabbit heart. Hill GE, Wong KC, Shaw CL, Sentker CR, Blatnick RA. Anesthesiology; 1978 May; 48(5):315-9. PubMed ID: 646148 [No Abstract] [Full Text] [Related]
29. Effects of some catecholamines infused into the hypothalamus of young chickens. Marley E, Stephenson JD. Br J Pharmacol; 1969 May; 36(1):194P-195P. PubMed ID: 5768105 [No Abstract] [Full Text] [Related]
34. Potentiation by hydrocortisone of responses to catecholamines in vascular smooth muscle. Besse JC, Bass AD. J Pharmacol Exp Ther; 1966 Nov; 154(2):224-38. PubMed ID: 5922985 [No Abstract] [Full Text] [Related]
35. [Effects of alpha and beta blocker properties of parahydroxybenzonitrile on the cardiovascular system of rats]. Cheav SL, Kirkiacharian S, Piéri F, Poisson D. Ann Pharm Fr; 1998 Nov; 56(5):205-8. PubMed ID: 9805819 [Abstract] [Full Text] [Related]
36. The role of bioactivation on the pharmacology of the potent monoamine oxidase inhibitor 5-oxo-N-(D-trans-2-phenylcyclopropyl)-L-2-pyrrolidine-carboxamide (EX-4883). Lowe MC, Horita A. Proc West Pharmacol Soc; 1969 Nov; 12():87. PubMed ID: 5812307 [No Abstract] [Full Text] [Related]
37. Corticosteroid potentiation of catecholamine bronchodilator drugs: possible mechanisms of action. Jeffery J, Garcia J, Avner BP. Proc West Pharmacol Soc; 1979 Nov; 22():149-53. PubMed ID: 515045 [No Abstract] [Full Text] [Related]
39. Influence of propranolol and ICI 50,172 on the cardiovascular actions of catecholamines as modified by ergotamine. Osswald W, Guimarães S, Garrett J. J Pharmacol Exp Ther; 1970 Aug; 174(2):315-22. PubMed ID: 5451366 [No Abstract] [Full Text] [Related]
40. [On the mechanism of toxic effect of triethylamine]. Chernen'kiĭ IK. Farmakol Toksikol; 1968 Aug; 31(6):750-2. PubMed ID: 4388891 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]